Tiphanie Fais

Clermont-ferrand, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Colibactin-producing Escherichia coli enhance resistance to chemotherapeutic drugs by promoting epithelial to mesenchymal transition and cancer stem cell emergence.

Colibactin-producing Escherichia coli enhance resistance to chemotherapeutic drugs by promoting epithelial to mesenchymal transition and cancer stem cell emergence.

Journal: Gut microbes
Published: February 20, 2024

Comparison of homogenization with the GentleMacs Dissociator vs conventional methods for routine tissue processing.

Comparison of homogenization with the GentleMacs Dissociator vs conventional methods for routine tissue processing.

Journal: Letters in applied microbiology
Published: October 22, 2021

Propionate catabolism by CD-associated adherent-invasive E. coli counteracts its anti-inflammatory effect.

Propionate catabolism by CD-associated adherent-invasive E. coli counteracts its anti-inflammatory effect.

Journal: Gut microbes
Published: March 26, 2021

Yersiniabactin Siderophore of Crohn's Disease-Associated Adherent-Invasive Escherichia coli Is Involved in Autophagy Activation in Host Cells.

Yersiniabactin Siderophore of Crohn's Disease-Associated Adherent-Invasive Escherichia coli Is Involved in Autophagy Activation in Host Cells.

Journal: International journal of molecular sciences
Published: March 04, 2021

Crohn's Disease-Associated Adherent-Invasive Escherichia coli Manipulate Host Autophagy by Impairing SUMOylation.

Crohn's Disease-Associated Adherent-Invasive Escherichia coli Manipulate Host Autophagy by Impairing SUMOylation.

Journal: Cells
Published: December 08, 2018

Metabolic adaptation of adherent-invasive Escherichia coli to exposure to bile salts.

Metabolic adaptation of adherent-invasive Escherichia coli to exposure to bile salts.

Journal: Scientific reports
Published: August 07, 2018

Colibactin: More Than a New Bacterial Toxin.

Colibactin: More Than a New Bacterial Toxin.

Journal: Toxins
Published: March 16, 2018

Antibiotic Activity of Escherichia coli against Multiresistant Staphylococcus aureus.

Antibiotic Activity of Escherichia coli against Multiresistant Staphylococcus aureus.

Journal: Antimicrobial agents and chemotherapy
Published: September 08, 2016

Targeting colorectal cancer-associated bacteria: A new area of research for personalized treatments.

Targeting colorectal cancer-associated bacteria: A new area of research for personalized treatments.

Journal: Gut microbes
Published: March 24, 2016

Impact of CDT Toxin on Human Diseases.

Impact of CDT Toxin on Human Diseases.

Journal: Toxins
Published: February 10, 2016

The Vat-AIEC protease promotes crossing of the intestinal mucus layer by Crohn's disease-associated Escherichia coli.

The Vat-AIEC protease promotes crossing of the intestinal mucus layer by Crohn's disease-associated Escherichia coli.

Journal: Cellular microbiology
Published: March 15, 2015

Small-molecule inhibitors prevent the genotoxic and protumoural effects induced by colibactin-producing bacteria.

Small-molecule inhibitors prevent the genotoxic and protumoural effects induced by colibactin-producing bacteria.

Journal: Gut
Published: March 17, 2014
Showing 1-12 of 12

Last Updated: 09/26/2026